How to manage a subdural hematoma (SDH) in a comatose patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Subdural Hematoma in a Comatose Patient

A comatose patient with acute subdural hematoma requires immediate urgent neurosurgical consultation and surgical evacuation if the hematoma is ≥10 mm thick or causes midline shift ≥5 mm, with surgery performed as soon as possible to reduce mortality. 1, 2

Initial Assessment and Stabilization

Immediate Priorities

  • Control life-threatening hemorrhage first if polytrauma is present, followed by urgent neurological evaluation including pupils, Glasgow Coma Scale motor score, and brain CT scan 1
  • Maintain systolic blood pressure >100 mmHg or mean arterial pressure >80 mmHg during resuscitation and any surgical intervention 1
  • Maintain PaO2 between 60-100 mmHg and PaCO2 between 35-40 mmHg to optimize cerebral perfusion while avoiding secondary brain injury 1

Hemodynamic Management

  • Avoid hypotension (systolic <110 mmHg) which worsens outcomes in brain-injured patients 1
  • Transfuse red blood cells if hemoglobin <7 g/dL, with higher thresholds considered for elderly patients or those with cardiovascular disease 1
  • Maintain euvolemia; patients may become dehydrated if diabetes insipidus develops 1

Surgical Decision-Making

Absolute Indications for Emergency Surgery

Surgical evacuation via craniotomy is mandatory for: 2

  • SDH thickness >10 mm on CT scan, regardless of GCS score
  • Midline shift >5 mm on CT scan, regardless of GCS score
  • GCS decline of ≥2 points from injury to admission
  • Asymmetric or fixed dilated pupils
  • Intracranial pressure >20 mmHg (once monitoring established)

Surgical Approach

  • Perform craniotomy with or without bone flap removal and duraplasty as the standard surgical technique for comatose patients 2
  • Surgery should be performed as soon as possible after indication is established, as timing affects mortality 1, 2, 3
  • Recent evidence shows trauma centers with higher surgical intervention rates have 30% lower mortality (adjusted OR 0.7) and better functional outcomes 3

Special Considerations

  • Acute SDH with mass effect requires time-critical transfer to neurosurgical center, even by local team if specialized transport unavailable 1
  • Surgical evacuation rates vary dramatically between centers (7-52%), but higher intervention rates correlate with improved survival 1, 3

Intracranial Pressure Management

ICP Monitoring

  • All comatose patients (GCS <9) with acute SDH require ICP monitoring, particularly those with radiological signs of intracranial hypertension 1
  • Insert ICP monitor after correcting coagulopathy (platelets >50,000/mm³ for systemic hemorrhage; higher values advisable for neurosurgery) 1
  • Maintain cerebral perfusion pressure ≥60 mmHg once ICP monitoring available, individualized based on autoregulation status 1

Medical Management of Elevated ICP

  • For impending cerebral herniation, use osmotherapy (mannitol) and/or temporary hypocapnia while awaiting emergency neurosurgery 1
  • Mannitol dosing: 0.25-2 g/kg as 15-25% solution over 30-60 minutes for adults 4
  • Use stepwise escalation approach for persistent intracranial hypertension, reserving aggressive interventions for refractory cases 1

Coagulation Management

Preoperative Optimization

  • Maintain prothrombin time/aPTT <1.5 times normal control before neurosurgery 1
  • Platelet count should exceed 50,000/mm³ minimum; higher values advisable for neurosurgical procedures including ICP probe insertion 1
  • Use point-of-care testing (TEG/ROTEM) if available to guide coagulation optimization 1
  • During massive transfusion, use RBC:plasma:platelet ratio of 1:1:1, then adjust based on laboratory values 1

Post-Evacuation Management

Monitoring for Complications

  • Persistent coma after SDH evacuation may result from cerebral hyperperfusion, which can cause delayed recovery lasting several weeks 5
  • Exclude other causes of persistent coma: residual midline shift, cerebral infarction, nonconvulsive seizures, metabolic derangements, and infection 5
  • Serial neurological examinations (GCS motor score and pupillary reactions) after achieving physiological stability are essential 1

Prognostic Considerations

  • Pupil reactivity is a critical prognostic indicator: mortality rates are 44.4% for reactive pupils, 57.1% for unilaterally unreactive, and 85.9% for bilaterally unreactive pupils 6
  • Patients with GCS 3 have 80.7% mortality overall, but surgical intervention reduces this to 64.3% compared to 91.0% with conservative management 6
  • Allow 24-72 hours of physiological stabilization before definitive prognostication, as some patients show delayed but meaningful recovery 1, 5

Critical Pitfalls to Avoid

  • Do not delay surgery in patients meeting surgical criteria; earlier intervention correlates with better outcomes 2, 3
  • Avoid hypotension and hypoxia during resuscitation and transfer, as these worsen secondary brain injury 1
  • Do not use mannitol in patients with severe dehydration, anuria, or pulmonary edema, as it may cause renal failure and fluid overload 4
  • Mannitol may increase cerebral blood flow and worsen intracranial hypertension in children during first 24-48 hours post-injury 4
  • Do not perform external ventricular drain alone for posterior fossa hemorrhage with compressed basal cisterns, as this may be harmful 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cerebral Hyperperfusion and Delayed Coma Recovery after Subdural Hematoma Evacuation.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.